REFERENCES
- Ballas SK. Current issues in sickle cell pain and its management. Hematology Am Soc Hematol Educ Program. 2007:97–105.
- Ballas SK. Sickle Cell Pain. Progress in Pain Research and Management, Vol. 11. Seattle: IASP Press, 1998.
- Zimmerman SA, Davis JS, Schultz WH, Ware. Subclinical parvovirus B19 infection in children with sickle cell anemia. J Pediatr Hematol Oncol. 2003;25(5):387–389.
- Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion. 2006;46(1):105–110.
- Karam LB, Disco D, Jackson SM, Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels. Pediatr Blood Cancer. 2008;50(1):62–65.
- Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37–47.
- Ballas SK. Pain management of sickle cell disease. Hematol/Oncol Clin Am. 2005;19(5):785–802.
- Coluzzi PH, Schwartzberg L, Conroy JD, Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain. 2001;91(1–2):123–130.
- Ballas SK, Bauserman RL, McCarthy WF, Castro OL, Smith WR, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home. J Pain Symptom Manage. 2010;40(6):870–882.
- Mayer RA, Ringkamp M, Campbell JN, . Peripheral mechanisms of cutaneous nociception. In: McMahon SB, Koltzenburg M, Eds. Wal and Melzack’s Textboob of Pain, 5th ed. New York: Elsevier. 2006:9–34.
- McMahon SB, Koltzenburg M, Eds. Wall and Melzack’s Textbook of Pain, 5th ed. New York: Elsevier, 2006.
- Fishman SM, Balantyne JC, Rathmell JP, Eds. Bonica’s Management of Pain, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2010.
- Benjamin LJ. Nature and treatment of the acute painful episode in sickle cell disease. In: Steinberg MH, Ed. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press, 2001:671–710.
- Benjamin LJ, Dampier CD, Jacox A, Guideline for the management of acute and chronic pain in sickle cell disease. American Pain Society Clinical Practice Guidelines Series No. 1. Glenview, IL, 1999.
- Ballas SK. Pain and sickle cell disease. In: Fishman SM, Balantyne JC, Rathmell JP, Eds. Bonica’s Management of Pain, 4th ed. Philadelphia: Lippincott Williams & Wilkins. 2010:806–827.
- Shaiova L, Wallenstein D. Outpatient management for sickle cell pain with chronic opioid pharmacotherapy. J Natl Med Assoc. 2004; 96(7):984–986.
- Ballas SK. The treatment of pain in adults with sickle cell disease. Am J Hematol. 1990;34(1):49–54.
- van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol. 2007; 82(11):955–960.
- Chou R, Fanciullo GJ, Fine PG, ; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130.
- Weissman DE, Haddox JD. Opioid pseudoaddiction—an iatrogenic syndrome. Clin J Pain. 1998;14(4):280–281.
- Canfield MC, Keller CE, Frydrych LM, Ashrafioun L, Purdy CH, Blondell RD. Prescription opioid use among patients seeking treatment for opioid dependence. J Addict Med. 2010;4(2):108–113.